Detalhe da pesquisa
1.
Correction to: Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study.
Heart Vessels
; 35(4): 603-604, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30972549
2.
Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study.
Heart Vessels
; 34(4): 698-710, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30406819
3.
Comparison of Efficacy and Safety of Azilsartan and Olmesartan in Patients With Essential Hypertension.
Int Heart J
; 58(3): 416-421, 2017 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-28496022
4.
Efficacy and Safety of Combination Therapy Consisting of Angiotensin II Type 1 Receptor Blocker, Calcium Channel Blocker and Hydrochlorothiazide in Patients With Hypertension.
J Clin Med Res
; 9(2): 98-103, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28090225
5.
Efficacy and safety of combination therapy of high-dose losartan and hydrochlorothiazide in patients with hypertension.
J Renin Angiotensin Aldosterone Syst
; 16(4): 1078-84, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25143336
6.
Efficacy and safety of a single-pill fixed-dose combination of high-dose telmisartan/hydrochlorothiazide in patients with uncontrolled hypertension.
J Renin Angiotensin Aldosterone Syst
; 13(3): 394-400, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22427308